Business Standard

Don’t miss the latest developments in business and finance.

Dr Reddy's Laboratories receives EIR for its API manufacturing plant at Miryalaguda

Bs_logoImage
Capital Market
Last Updated : Jun 14 2017 | 9:47 AM IST

From USFDA

Dr Reddy's Laboratories has received an Establishment Inspection Report from the USFDA following closure of audit of its API manufacturing plant at Miryalaguda. The Company was issued a form 483 with three observations subsequent to the audit of the said unit in February 2017.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Jun 14 2017 | 9:29 AM IST

Next Story